|
|
|
|
|
|
Novo Nordisk A/S (NVO)
|
|
43.55 +0.98 (+2.30%)
|
7/20/2017 4:02pm
|
|
Open:
|
43.07
|
Pre. Close:
|
42.57
|
|
High:
|
43.71
|
Low:
|
43.07
|
|
Volume:
|
1,555,468
|
Market Cap:
|
108.69B
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
43.68 - 44
|
44 - 44.3
|
|
Low:
|
42.36 - 42.73
|
42.73 - 43.07
|
|
Close:
|
43.05 - 43.51
|
43.51 - 43.94
|
|
|
|
|
|
|
Technical analysis (as of: 2017-07-20 4:39:59 PM)
|
|
Overall:
|
|
|
Stoxline posted a BUY today, same as yesterday. This stock seems to continue bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, upward move is expected.
|
|
Target:
|
Six months: 52.05 One year: 60.79
|
|
Support:
|
Support1: 42.77 Support2: 41.67
|
|
Resistance:
|
Resistance1:
44.56 Resistance2: 52.05
|
|
Pivot:
|
42.67 
|
|
Moving Averages:
|
MA(5): 43.08 MA(20): 42.99
MA(100): 39.05 MA(250): 39.61 
|
|
MACD:
|
MACD(12,26):
0.16 Signal(12,26,9): 0.14
|
|
%K %D:
|
%K(14,3): 68.39 %D(3): 54.50
|
|
RSI:
|
RSI(14): 58.89
|
|
52-Week:
|
High: 57.41
Low: 30.89 Change(%): -20.8
|
|
Average Vol(K):
|
3-Month: 199110
10-Days 86101
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed above its Short term moving average. Short term moving average is currently below mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is NEUTRAL in short-term; and NEUTRAL in mid-long term.NVO has closed below upper band by 4.3%. Bollinger Bands are 39.1% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
|
|
|
Headline News
|
|
Sat, 10 Jun 2017 09:56:15 GMT
Why Novo Nordisk A/S (ADR) Jumped 10.6% In May
Tue, 22 Nov 2016 16:55:25 GMT
Portfolio Update - Novo Nordisk Purchased
Thu, 29 Sep 2016 08:14:13 GMT
Novo Nordisk to ax 1000 jobs as competition grows
Thu, 04 May 2017 20:15:00 GMT
Novo Nordisk A/S Jumps Over Its Lowered Bar
Wed, 08 Mar 2017 14:15:00 GMT
Is Novo Nordisk A/S (ADR)(NYSE: NVO) failing to meet expectations
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
